Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Add Yahoo as a preferred source to see more of our stories on Google. "It came back stage 1 cervical cancer called adenocarcinoma," she said about the results of her recent cone biopsy. "Obviously not ...

Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical cancer screening by a clinician, finds a study from China published by The ...